{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T07:45:02Z","timestamp":1794296702192,"version":"4.9.0"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2020,6]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The role of imaging in the management of Rosai-Dorfman disease (RDD), a rare non-Langerhans cell histiocytosis, is not clearly defined. We present an analysis of FDG PET\/CT findings obtained for initial disease characterization, follow-up evaluation, and treatment planning for this disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>From an institutional pathology database (2001\u20132018), we identified RDD patients who underwent FDG PET\/CT scans either as part of clinical care or when done as part of clinical trials. For all scans, sites of abnormal FDG uptake were assessed, and SUVmax was measured. Comparison of PET\/CT findings was made with anatomic (CT\/MRI-based) imaging, where available. Instances of changing treatment based on PET\/CT were recorded.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We reviewed 109 FDG PET\/CT scans in 27 patients with RDD. Five of 27 patients had only nodal\/cutaneous disease, whereas 22 patients had extranodal disease, most commonly in bone (n = 9) and central nervous system (n = 7). PET\/CT identified sites of active disease in 24 of 27 patients. All identified bone and extraskeletal lesions, except for a brain lesion in 1 patient, were FDG-avid. In 6 of 20 patients (30%) with available prior CT or MRI, PET\/CT demonstrated additional RDD lesions (bones: n = 5, pleura: n = 1) that were not apparent on anatomic imaging; 3 of these lesions were outside the CT field of view, and 3 were not recognized on CT. Overall, 13 of 109 PET\/CT scans led to a change in management, affecting 41% (11\/27) of patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>FDG PET\/CT was valuable in defining disease extent and optimizing treatment strategy in patients with RDD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/rlu.0000000000003014","type":"journal-article","created":{"date-parts":[[2020,4,29]],"date-time":"2020-04-29T16:47:41Z","timestamp":1588178861000},"page":"e260-e266","source":"Crossref","is-referenced-by-count":43,"title":["Rosai-Dorfman Disease\u2014Utility of 18F-FDG PET\/CT for Initial Evaluation and Follow-up"],"prefix":"10.1097","volume":"45","author":[{"given":"Sonia","family":"Mahajan","sequence":"first","affiliation":[{"name":"Department of Radiology, NYU School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reiko","family":"Nakajima","sequence":"additional","affiliation":[{"name":"Radiology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariko","family":"Yabe","sequence":"additional","affiliation":[{"name":"Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet","family":"Dogan","sequence":"additional","affiliation":[{"name":"Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary A.","family":"Ulaner","sequence":"additional","affiliation":[{"name":"Radiology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Yahalom","sequence":"additional","affiliation":[{"name":"Radiation Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariela","family":"Noy","sequence":"additional","affiliation":[{"name":"Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eli L.","family":"Diamond","sequence":"additional","affiliation":[{"name":"Neurology, Memorial Sloan Kettering Cancer Center, New York, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heiko","family":"Sch\u00f6der","sequence":"additional","affiliation":[{"name":"Radiology"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,4,29]]},"reference":[{"key":"bib1-20230925","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1182\/blood-2018-03-839753","article-title":"Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease","volume":"131","year":"2018","journal-title":"Blood"},{"key":"bib2-20230925","first-page":"1169","article-title":"Adenitis with lipid excess, in children or young adults, seen in the Antilles and in Mali (4 cases)","volume":"58","year":"1965","journal-title":"Bull Soc Pathol Exot Filiales"},{"key":"bib3-20230925","first-page":"63","article-title":"Sinus histiocytosis with massive lymphadenopathy. A newly recognized benign clinicopathological entity","volume":"87","year":"1969","journal-title":"Arch Pathol"},{"key":"bib5-20230925","article-title":"Clinicopathological features, treatment approaches, and outcomes in Rosai-Dorfman disease","volume":"Haematol-2019","year":"2019","journal-title":"Haematologica"},{"key":"bib6-20230925","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1158\/2159-8290.CD-15-0913","article-title":"Diverse and targetable kinase alterations drive histiocytic neoplasms","volume":"6","year":"2016","journal-title":"Cancer Discov"},{"key":"bib7-20230925","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1007\/s12105-016-0709-6","article-title":"Rosai-Dorfman disease harboring an activating KRAS K117N missense mutation","volume":"10","year":"2016","journal-title":"Head Neck Pathol"},{"key":"bib8-20230925","first-page":"e89473","article-title":"Real-time genomic profiling of histiocytoses identifies early-kinase domain BRAF alterations while improving treatment outcomes","volume":"2","year":"2017","journal-title":"JCI Insight"},{"key":"bib9-20230925","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1038\/modpathol.2017.55","article-title":"Mutually exclusive recurrent KRAS and MAP2K1 mutations in Rosai-Dorfman disease","volume":"30","year":"2017","journal-title":"Mod Pathol"},{"key":"bib10-20230925","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s00428-017-2173-4","article-title":"Is Rosai-Dorfman disease a reactive process? Detection of a MAP2K1 L115V mutation in a case of Rosai-Dorfman disease","volume":"471","year":"2017","journal-title":"Virchows Arch"},{"key":"bib11-20230925","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/s41586-019-1012-y","article-title":"Efficacy of MEK inhibition in patients with histiocytic neoplasms","volume":"567","year":"2019","journal-title":"Nature"},{"key":"bib12-20230925","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1056\/NEJMc1713676","article-title":"Rosai-Dorfman disease with activating KRAS mutation\u2014response to cobimetinib","volume":"377","year":"2017","journal-title":"N Engl J Med"},{"key":"bib13-20230925","article-title":"Erdheim-Chester disease with concomitant Rosai-Dorfman like lesions: a distinct entity mainly driven by MAP2K1","volume":"haematol-2019","year":"2019","journal-title":"Haematologica"},{"key":"bib14-20230925","doi-asserted-by":"crossref","first-page":"e9372","DOI":"10.1097\/MD.0000000000009372","article-title":"Multimodality imaging-based evaluation of Rosai-Dorfman disease in the head and neck: a retrospective observational study","volume":"96","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"bib15-20230925","doi-asserted-by":"crossref","first-page":"174","DOI":"10.4103\/0971-5851.92826","article-title":"Multicentric sinus histicytosis (Rosai-Dorfman disease): computed tomography, magnetic resonance imaging findings","volume":"32","year":"2011","journal-title":"Indian J Med Paediatr Oncol"},{"key":"bib16-20230925","first-page":"e49","article-title":"Paranasal sinus localization of Rosai Dorfman disease: long-term evolution and importance of magnetic resonance imaging","volume":"37","year":"2008","journal-title":"J Otolaryngol Head Neck Surg"},{"key":"bib17-20230925","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1001\/jamaoncol.2017.5029","article-title":"Vemurafenib for BRAF V600\u2013mutant Erdheim-Chester disease and Langerhans cell histiocytosis: analysis of data from the histology-independent, phase 2, open-label VE-BASKET study","volume":"4","year":"2018","journal-title":"JAMA Oncol"},{"key":"bib18-20230925","first-page":"411","article-title":"Reproducible and sustained efficacy of targeted therapy with vemurafenib in patients with BRAFV600E-mutated Erdheim-Chester disease","volume":"33","year":"2014","journal-title":"J Clin Oncol"},{"key":"bib19-20230925","doi-asserted-by":"crossref","first-page":"e177","DOI":"10.3324\/haematol.2017.185298","article-title":"Single-agent dabrafenib for BRAFV600E-mutated histiocytosis","volume":"103","year":"2018","journal-title":"Haematologica"},{"key":"bib20-20230925","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/01.rlu.0000114018.07676.15","article-title":"Demonstration of increased FDG activity in Rosai-Dorfman disease on positron emission tomography","volume":"29","year":"2004","journal-title":"Clin Nucl Med"},{"key":"bib21-20230925","doi-asserted-by":"crossref","first-page":"W187","DOI":"10.2214\/AJR.10.4778","article-title":"Rosai-Dorfman disease in neuroradiology: imaging findings in a series of 10 patients","volume":"196","year":"2011","journal-title":"AJR Am J Roentgenol"},{"key":"bib22-20230925","doi-asserted-by":"crossref","first-page":"e420","DOI":"10.1097\/RLU.0000000000000853","article-title":"18F-FDG PET\/CT follow-up of Rosai-Dorfman disease","volume":"40","year":"2015","journal-title":"Clin Nucl Med"},{"key":"bib23-20230925","first-page":"e392","article-title":"18F-FDG PET\/CT imaging of extranodal Rosai-Dorfman disease with hepatopancreatic involvement\u2014a pictorial and literature review","volume":"7","year":"2015","journal-title":"Cureus"},{"key":"bib24-20230925","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1097\/RLU.0000000000001705","article-title":"Spontaneous recovery of Rosai-Dorfman disease on FDG PET\/CT","volume":"42","year":"2017","journal-title":"Clin Nucl Med"},{"key":"bib25-20230925","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jmoldx.2014.12.006","article-title":"Memorial Sloan Kettering\u2013Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): a hybridization capture-based next-generation sequencing clinical assay for solid tumor molecular oncology","volume":"17","year":"2015","journal-title":"J Mol Diagn"},{"key":"bib26-20230925","doi-asserted-by":"crossref","first-page":"e225","DOI":"10.1016\/j.jaad.2012.04.025","article-title":"Cutaneous Rosai-Dorfman disease of the right ear responsive to radiotherapy","volume":"67","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"bib27-20230925","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1186\/1752-1947-6-411","article-title":"18F-fluoro-deoxyglucose positron emission tomography\/ computed tomography scan findings in Rosai-Dorfman disease with IgG4-positive plasma cell infiltration mimicking breast malignancy: a case report and literature review","volume":"6","year":"2012","journal-title":"J Med Case Reports"},{"key":"bib28-20230925","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s00256-012-1382-9","article-title":"The use of FDG-PET\/CT in extranodal Rosai-Dorfman disease of bone","volume":"41","year":"2012","journal-title":"Skeletal Radiol"},{"key":"bib29-20230925","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1097\/RLU.0000000000002776","article-title":"FDG PET\/CT image for a Rosai-Dorfman disease with pituitary and bone involvement in a pediatric patient","volume":"44","year":"2019","journal-title":"Clin Nucl Med"},{"key":"bib30-20230925","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/RLU.0000000000002501","article-title":"An isolated osseous Rosai-Dorfman disease shown on FDG PET\/CT","volume":"44","year":"2019","journal-title":"Clin Nucl Med"},{"key":"bib31-20230925","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1097\/RLU.0000000000001921","article-title":"Isolated multinodular soft-tissue Rosai-Dorfman disease on FDG PET\/CT","volume":"43","year":"2018","journal-title":"Clin Nucl Med"},{"key":"bib32-20230925","doi-asserted-by":"crossref","first-page":"774","DOI":"10.2967\/jnumed.117.200741","article-title":"18F-FDG PET\/CT in Erdheim-Chester disease: imaging findings and potential BRAF mutation biomarker","volume":"59","year":"2018","journal-title":"J Nucl Med"},{"key":"bib33-20230925","first-page":"1319","article-title":"Rosai-Dorfman disease presenting as extranodal renal mass","volume":"66","year":"2005","journal-title":"Urology"},{"key":"bib34-20230925","first-page":"64","article-title":"Isolated localization of Rosai Dorfman disease as renal mass: a case report and review of literature","volume":"24","year":"2016","journal-title":"Pan Afr Med J"},{"key":"bib35-20230925","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5582\/irdr.2015.01047","article-title":"Rosai-Dorfman disease and the heart","volume":"5","year":"2016","journal-title":"Intractable Rare Dis Res"},{"key":"bib36-20230925","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1159\/000475588","article-title":"Review of Rosai-Dorfman disease: new insights into the pathogenesis of this rare disorder","volume":"138","year":"2017","journal-title":"Acta Haematol"},{"key":"bib37-20230925","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1007\/s00277-018-3436-0","article-title":"Histiocytic cell neoplasms involving the bone marrow: summary of the workshop cases submitted to the 18th meeting of the European Association for Haematopathology (EAHP) organized by the European bone marrow working group, Basel 2016","volume":"97","year":"2018","journal-title":"Ann Hematol"},{"key":"bib38-20230925","doi-asserted-by":"crossref","first-page":"4060","DOI":"10.18632\/oncotarget.2061","article-title":"Potential clinical implications of BRAF mutations in histiocytic proliferations","volume":"5","year":"2014","journal-title":"Oncotarget"},{"key":"bib39-20230925","doi-asserted-by":"crossref","first-page":"e377","DOI":"10.3324\/haematol.2018.190934","article-title":"BRAF V600E mutation detected in a case of Rosai-Dorfman disease","volume":"103","year":"2018","journal-title":"Haematologica"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000003014","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T02:07:46Z","timestamp":1695607666000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000003014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,29]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000003014","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4,29]]}}}